Abstract: A guide catheter system for use in treating the sinus cavity or Eustachian tube is described. The system includes a guide catheter that has a proximal end and a distal end and an elongate shaft between the proximal end and the distal end and a guidewire. The guide catheter includes a deflection feature on a distal tip of the distal end for deflecting the guidewire at a predetermined angle.

Abstract: A balloon coating method is disclosed for forming a coating layer containing a water-insoluble drug on an outer surface of a balloon of a balloon catheter. The balloon coating method includes an application step in which, where a pipe-shaped dispensing tube formed from a polyolefin for supplying a coating solution containing the water-insoluble drug and a solvent is formed at its end portion with an opening portion for discharging the coating solution therethrough and when the end portion side of the dispensing tube is placed in contact with the outer surface of the balloon while the balloon is rotated about an axis of the balloon, the coating solution is discharged through the opening portion and applied to the outer surface of the balloon while the dispensing tube is moved relative to the balloon in an axial direction of the balloon.

Abstract: A low profile occlusion catheter having a guiding atraumatic tip that prevents entry of the balloon into collateral vessels. The occlusion catheter system is particularly well suited for use in vascular occlusion and includes a pressure monitoring line to monitor the degree and state of occlusion.

Abstract: The present disclosure includes an expandable medical device and outer sheath combination. The outer sheath is capable of being split to form multiple sheath sections that may be peeled back to expose a portion or all of the expandable medical device. The medical device, as well as the outer sheath, may include one or more therapeutic agents for delivery to a treatment area within a patient.

Abstract: Systems and methods for systems and methods for focal cooling of the brain and spinal cord are disclosed. Some embodiments may be directed to a neuroprotection system that includes a cerebrospinal fluid processing platform. Embodiments may provide rapid and selective spinal cord hypothermia and drainage. Embodiments may be tailored to selective spinal cord cooling, pressure monitoring and automated drainage. Embodiments may enable local hypothermic neuroprotection, limit the stress of systemic cooling, minimize secondary neuronal damage and achieve maximal neuroprotection while at the same time improving workflow as a result of automated drainage. Embodiments may include a multi-lumen catheter, a drainage collection reservoir bag, a pump to circulate coolant, sensor hardware and controllers to modulate the flow of a heat transfer fluid for cooling to modulate therapeutic hypothermia and re-warming. Certain embodiments may include extracorporeal cooling of cerebrospinal fluid (CSF).

Abstract: An adjustable hydrocephalus valve is used for pressure equalization of the cerebrospinal fluid in the cranium of a hydrocephalus patient. The adjustable hydrocephalus valve is implantable in a patient. The valve controls drainage of excess cerebrospinal fluid. The valve has an inlet, an outlet, and a housing through which cerebrospinal fluid flows between the inlet and the outlet. The valve also has a spring, an adjusting mechanism, and at least one rotatable part, which are disposed in the housing.

Abstract: A medical device and treatment method for treating veins. The medical device includes: an elongated outer sheath; an inner member extending through inside of the outer sheath, the inner member protruding distally beyond the outer sheath; an expansion portion positioned between a distal portion of the outer sheath and a distal portion of the inner member, the expansion portion having a plurality of linear material portions extending along an axial direction of the inner member, the expansion portion being expandable in a radial direction of the inner member; a biasing member disposed inside the outer sheath biasing the inner member proximally relative to the outer sheath; and a fixing portion configured to fix the relative positions of the inner member and the outer sheath in a state in which the expansion portion has been expanded. The fixing portion is also configured to be released from the fixed state.

Abstract: A controlled release nanoparticulate matter delivery system includes a plurality of thermoresponsive modules containing a respective nanoparticulate matter. Each thermoresponsive module is selectively operable in at least one of a heating mode that releases the nanoparticulate matter and a cooling mode that inhibits release of the nanoparticulate matter. A control module is in electrical communication with the plurality of thermoresponsive modules. The control module is configured to determine a temperature of each thermoresponsive module and to select the at least one heating mode and cooling mode based on the temperature. The heating and cooling mode may be selected in response to a desired dosing profile and/or a biometric condition.

Abstract: Method for targeted application of active agents to a target surface including the steps of: (a) capturing an image of the target surface; (b) transforming the image into a digital geometric representation of the target surface; (c) forming an applicator mask having an applicator surface with a three-dimensional shape corresponding to the target surface; (d) disposing the active agent on the applicator surface of the applicator mask; (e) disposing the applicator mask on the target surface so that the active agent is in contact with the target surface; and (f) removing the applicator mask from the target surface while leaving at least some of the active agent in contact with the target surface.

Abstract: An applicator including a body with a hair separator and an application aperture. The hair separator and the application aperture are structured to expose a portion of the animal's skin so that the user can see how much of a treatment is being applied and ensure the treatment is applied substantially to the animal's skin.

Abstract: A medicated patch applicator includes a portable handle having a centrally registered longitudinal axis, a flexible frame pivotally connected to the handle and selectively articulated relative thereto, and an implement adjustably coupled to a distal end of the handle and disposed at a proximal end of the frame. Such an implement is located adjacent to a juncture of the frame and the handle such that the implement linearly protrudes outwardly from the handle along the centrally registered longitudinal axis. Advantageously, the implement is capable of removing an existing back liner of an existing medicated patch during an application process of the existing medicated patch.

Abstract: Various exemplary devices and methods are provided for performing surgical procedures. In general, one or more adjuncts can be used in conjunction with surgical instruments. The adjunct(s) can have medicant(s) thereon and/or therein. The medicant(s) can vary depending on the desired effect of the medicant(s) on surrounding tissue. As a non-limiting example, medicant(s) can be provided to influence hemostasis, inflammation, macrophages, and/or fibroblasts. When used in conjunction with a surgical stapler, the adjunct(s) can be disposed between and/or on jaws of the stapler, incorporated into a staple cartridge disposed in the jaws, or otherwise placed in proximity to the staples. When staples are deployed, the adjunct(s) can remain at the treatment site with the staples.

Abstract: Hemostasis valves and methods for making and using hemostasis valves are disclosed. An example hemostasis valve may include a main body having a proximal end region. A cartridge may be at least partially disposed within the proximal end region. The cartridge may include a seal member. The seal member may be designed to shift between an open configuration and a sealed configuration. A plunger, having an inner tubular region and a distal end, may be coupled to the proximal end region of the main body. The distal end of the inner tubular region may be spaced a clearance distance from a proximal end of the seal member so that when the seal member is in the sealed configuration and exposed to pressures of 80-250 pounds per square inch, the seal member deflects into contact with the distal end of the inner tubular region and remains in the sealed configuration.

Abstract: Break-away connectors are disclosed. The break-away connectors may be configured to be coupled in at least two configurations, for example, a high force configuration and a low force configuration. The break-away connectors may also be incrementally adjustable between the high force configuration and the low force configuration. The break-away connectors may be coupled to a first medical device and a second medical device. Methods of using and/or coupling the break-away connectors are also disclosed.

Abstract: A coupling for fluid-tight connection of two fluid-guiding portions in medical applications. The coupling is an axially lockable quick-connect coupling and comprises a male coupling portion having a continuous first passage and a female coupling portion adapted to be slipped over the male coupling portion and having a continuous second passage. A preferably circumferential radial sealing is provided on the outer periphery of the male coupling portion and/or on the inner periphery of the female coupling portion.

Abstract: Methods and apparatus for cleaning a central venous catheter port are disclosed. An apparatus includes a body, a coupling configured to connect the body to the hub, a cleaning cap coupled to the body, and an actuator disposed within the body for rotating and translating the cap relative to the hub. The cleaning cap includes a cap body defining a cavity and a cleaning member disposed within the cavity, the cleaning member having threads that engage with the threads on the hub.

Abstract: A fluid control device includes a piezoelectric pump, an inhaler, and a valve. The piezoelectric pump has a gas suction hole and a gas discharge hole. The inhaler has a container, an inhalation port, and a connection hole. The valve has a first ventilation hole, a second ventilation hole, a third ventilation hole, a first valve housing, a second valve housing, and a valve body. The first ventilation hole of the valve is connected to the connection hole of the inhaler. The second ventilation hole of the valve is connected to the suction hole of the piezoelectric pump. The third ventilation hole of the valve is opened to the atmosphere. The valve body is held between the first valve housing and the second valve housing, and configures a first region and a second region.

Abstract: The disclosure relates to a reduced Larsen Effect electrode. Specifically, the disclosure relates to an electrode with an insulation-coated electrode wire coaxially surrounded over a substantial portion thereof, by predetermined assembly of alternating rigid and isolating layers.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, a first prong with a proximal end attached to the housing and a distal end extending away from the housing, a first defibrillator coil on the distal end of the first prong, and a first electrode on the device. The clip is configured to anchor the device to a muscle, a bone, and/or a tissue. The first prong is configured to be positioned inferior to a heart. Therapeutic circuitry in the housing is in electrical communication with the first defibrillator coil and the first electrode and is configured to deliver a shock to the heart through the first defibrillator coil.

Abstract: Fully implantable cochlear implant systems can include a cochlear electrode, a stimulator in electrical communication with the cochlear electrode, a signal processor in communication with the stimulator, and an implantable battery and/or communication module in communication with the signal processor. A cochlear implant network can include an external device in wireless communication with the fully implantable cochlear implant system via one or more system components, such as the implantable battery and/or communication module, the stimulator, and/or the signal processor. The external device can be configured to wirelessly communicate signals to the fully implantable cochlear implant system such as control signals and/or audio signals. Networks can include a plurality of external devices capable of interfacing with one or more implantable components of a fully implantable cochlear implant system.

Abstract: Implantable medical leads and implantable lead extensions include a shield. The implantable medical lead is coupled to the implantable lead extension. Stimulation electrodes of the implantable medical lead contact stimulation connectors within a housing of the implantable extension to establish a conductive pathway for stimulation signals from filars of the implantable extension to filars of the implantable medical lead. Continuity is established between the shield of the implantable medical lead and the implantable extension by providing a radio frequency conductive pathway within the housing. The radio frequency conductive pathway extends from a shield of the implantable extension to a shield connector that contacts a shield electrode of the implantable medical lead. The radio frequency conductive pathway may have various forms such as a jumper wire or an extension of the shield within the implantable extension.

Abstract: A method of delivering pulsed electrical energy to a target tissue region includes delivering a first therapeutic pulse, the delivering of the first therapeutic pulse includes delivering a first pulse for a first time period, the first pulse having a first voltage amplitude. A second pulse is delivered immediately after the first pulse for a second time period, the second pulse having a second voltage amplitude configured to electroporate the target tissue region, the second time period being less than the first time period. A third pulse is delivered without delay after the second pulse for a third time period, the third pulse having a third voltage amplitude being at least one from the group consisting of substantially the same as the first amplitude, larger than the first amplitude, and less than the first amplitude.

Abstract: Timed stimulation of both somatosensory system and auditory system is controlled, in such a manner, that an individual's brain activity is altered through spike-timing dependent plasticity, thereby reducing or removing tinnitus.

Abstract: A motor device for stimulating muscle, including at least one electrode for generating electric current operatively attached to an electrode array and exposed on an inner surface of an array body, and a programming mechanism of a computer that executes an algorithm stored on non-transitory computer readable medium and includes an information storage mechanism and a user-operated interface in electrical connection with said at least one electrode for programming operation of said at least one electrode, said motor device being implanted in an individual and applying electric current to nerves at an area above an area of neurological damage.

Abstract: A device and method are provided for altering body mass composition in a human subject by applying galvanic vestibular stimulation (GVS) using electrodes placed in electrical contact with the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems. The current source includes a feedback loop for measuring a resistance across the subject's scalp and adjusting a voltage output to maintain a constant current across the subject's scalp. GVS may be applied for a predetermined period of time at regular intervals.

Abstract: The invention is an implantable electrode configuration having a carrier substrate of a biocompatible polymer in at least some areas and a freely accessible electrode surface applied to the carrier substrate or integrated into the carrier substrate on the carrier substrate surface in at least some areas is described and a method for producing the implantable electrode configuration. The electrode has a metallic base plate having a planar top side and bottom side, including at least one structural element protruding orthogonally from the top side. The planar surface of the metallic base plate is oriented parallel to the carrier substrate surface and the metallic base plate is enclosed by the biocompatible polymer, except for a first surface area of the at least one structural element which faces the carrier substrate surface and is the freely accessible electrode surface.

Abstract: A method is provided that includes positioning electrodes in or in contact with the head of a subject identified as in need of enhanced microglial cell activation. Control circuitry is activated to drive the electrodes to apply an electrical current to the brain of the subject, and to configure the electrical current to enhance microglial cell activation for taking up a substance from brain parenchyma. Other embodiments are also described.

Abstract: Methods for systematically testing a plurality of therapy programs in a spinal cord modulation system, and associated systems are disclosed. A representative method comprises loading a plurality of therapy programs into a signal generator, wherein individual therapy programs include parameters specifying electrode configuration, signal amplitude, and/or signal frequency. The programs are automatically activated for an automatically instructed period of time. The method includes automatically changing from one therapy program to another after the instructed period of time. The patient is queried for patient input corresponding to the therapy programs. The patient input is received via a remote. The patient input is correlated with a corresponding time of day and recorded in the signal generator. Thereafter, the patient input is retrieved from the signal generator.

Abstract: This disclosure relates to methods, devices, and systems for delivering and adjusting stimulation therapy. In one example, a method comprising delivering, by a stimulation electrode, electrical stimulation as a candidate therapy to a patient according to a set of candidate therapy parameters, the stimulation electrode located in proximity to the dorsal column of a patient; sensing, by a sensing electrode, an electrically evoked compound action potential (eECAP) signal in response to the delivery of the electrical stimulation; and classifying, by a processor, the sensed eECAP signal generated in response to the application of the candidate therapy relative to an eECAP baseline is disclosed.

Abstract: Short pulse width spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, modulation signal has pulse widths in the range of from about 10 microseconds to about 50 microseconds may be applied to the patient's spinal cord region to address chronic pain without using paresthesia or tingling to mask or cover the patient's sensation of pain. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Abstract: Systems, devices and methods for providing a pressurized fluid for facilitating conductive gel release prior to providing cardiac therapy to a patient are disclosed. A first system can include a chemical reaction chamber including a first chemical and a second chemical isolated from each other by a mechanical barrier. The mechanical barrier is configured to be compromised upon receiving a signal from an electrotherapy device controller such that the first chemical and second chemical come into contact to produce a sufficient amount of pressurized fluid. An alternative system can include a pressure source comprising a reservoir containing a pressurized fluid. The pressure source can also include at least one release mechanism configured to cause a release of the pressurized fluid from the reservoir to an exit port of the pressure source when a wearable medical device is preparing to deliver a therapeutic shock to a patient.

Abstract: Methods and devices are provided for, under control of one or more processors within an implantable medical device (IMD), delivering cardiac resynchronization therapy (CRT) at one or more pacing sites. The processors obtain cardiac signals, associated with a candidate beat, from multi-site left ventricular (MSLV) electrodes distributed along a left ventricle and analyze the cardiac signals to collect at least one of a MSLV conduction pattern or a MSLV morphology. The processors compare at least one of the MSLV conduction pattern or MSLV morphology to one or more associated templates. The processors then label the candidate beat as a pseudo-fusion beat based on the comparing and adjust the CRT based on the labeling.

Abstract: Systems and methods are provided for managing patient activated capture of transient data by an implantable medical device (IMD). The systems and methods collect transient data using the IMD. The collected transient data is stored in a temporary memory section of the IMD. The IMD receives a patient activated storage request including activation information related to a patient designated trigger point from an external device. The IMD transfers a segment of the transient data from the temporary memory section to a long-term memory, wherein the segment of transferred transient data is based on the trigger point. The activation information includes an elapsed time corresponding to a duration of time between entry of the trigger point and issuance of the patient activated storage request by an external activation device.

Abstract: A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue, and an electrode that is configured to contact an organ, a nerve, the first tissue, and/or a second tissue. The device further includes circuitry in the housing in electrical communication with the electrode that is configured to sense an electrical signal from the organ, the nerve, the first tissue, and/or the second tissue through the electrode; deliver electrical stimulation to the organ, the nerve, the first tissue, and/or the second tissue through the electrode; and/or deliver a signal to a drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, the first tissue, and/or the second tissue.

Abstract: Methods and systems for treating a patient using a time varying magnetic field are described. The treatment methods combine various approaches for aesthetic treatment. The methods are focused on enhancing a visual appearance of the patient. An exemplary method includes charging an energy storage device and discharging the energy storage device to a magnetic field generating device to generate the time-varying magnetic field. The time-varying magnetic field is applied to the patient.

Abstract: Combined methods for treating a patient using time-varying magnetic field are described. The methods include generating a time-varying magnetic field and applying the magnetic field to muscle fibers, neuromuscular plates, or peripheral nerves innervating muscle fibers within the body region of the patient such that a muscle is caused to contract. The treatment methods include generating optical waves and applying the optical waves to the body region of the patient to heat a target biological structure of the patient. The methods include providing an applicator housing a coil to generate the time-varying magnetic field and an optical waves generating device to generate the optical waves and attaching the applicator to the patient via a belt.

Abstract: A stationary trans-skull optogenetic stimulation module is provided and includes a sleeve to be inserted and positioned in a drilled hole of a skull of a subject, an optogenetic stimulating element, and a cover. The sleeve has a large aperture portion and a small aperture portion, and the optogenetic stimulating element and the cover can be installed with or disassembled from the large aperture portion. Thus, the operation time of syringe injection and phototherapeutic irradiation can be reduced, and the operation efficiency can be increased.

Abstract: Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.

Abstract: The present invention relates to a therapy system for the treatment of the skin and subdermis with light. The system comprises a NIR light source which produces light with a wavelength adapted to an absorption maximum for exciting molecular oxygen in aqueous solution; an image recognition unit for detecting papillary end arterioles and their x-y-z coordinates, wherein a respective depth underneath the skin surface is determined as the z-coordinate by an autofocus function; an optical system for the optical coupling of the light of the NIR light source and the pattern recognition unit to the skin, with a focussing unit to controllably position the light with at least one focus point in the skin; and a control unit to control the NIR light source, the image recognition unit, and the optical system.

Abstract: Stimulation of target cells using light, e.g., in vivo, is implemented using a variety of methods and devices. According to an example embodiment of the present invention, target cells are stimulated using an implantable arrangement. The arrangement includes an electrical light-generation means for generating light and a biological portion. The biological portion has a photosensitive bio-molecular arrangement that responds to the generated light by stimulating target cells in vivo.

Abstract: Disclosed herein is a method for regenerating retinal tissue which includes preparing a luminescent scaffold, implanting the luminescent scaffold in a portion of retina, for example subretinal area, emitting a green light from the luminescent nanoparticles in a luminescence phenomenon, and absorbing the emitted light by retinal cells for regenerating retinal tissue by stimulating the retinal cells. Moreover, preparing a luminescent scaffold may comprise synthesizing a plurality of luminescent particles, dispersing the luminescent particles in a polymeric matrix to form a luminescent composite, and electrospinning the luminescent composite to form the luminescent scaffold.

Abstract: A portable irradiation device is disclosed including: a hollow squeezing part operable to squeeze air therein out; a sucker having a first end opening portion and a second end opening portion, the first end opening portion being hermetically connected with the squeezing part, the second end opening portion being attachable to a human body by means of a difference in air pressure between inside and outside the sucker; and a blue light irradiation unit located in a space surrounded by the squeezing part, the sucker, or the squeezing part and the sucker. Also disclosed is a method for manufacturing a portable irradiation device.

Abstract: A system for inducing respiration according to one embodiment of the present invention comprises: an imaging unit for picking a respiration image of a patient; a respiration signal conversion unit for obtaining a respiration signal of the patient by image processing, and tracking and analyzing the respiration image of the patient obtained from the imaging unit; and a respiration determination unit for determining one or more of whether the obtained respiration signal is suitable for radiation treatment, whether the obtained respiration signal is stable, and whether a matching score between the respiration signal of the patient and a guide respiration is greater than a predetermined reference value; and a respiration guide unit for providing the respiration signal of the patient, obtained from the respiration signal conversion unit, together with a stored guide signal.

Abstract: The invention discloses a grating device for radiotherapy equipment. A tail-end position controller and a front-end position controller are simultaneously arranged, and can simultaneously verify a tail-end position and a middle position of each single grating blade and measure the time during which one grating blade arrives at the middle position from the tail-end position and/or the total number of revolutions of a motor at any time.

Abstract: The present disclosure provides a system and method for method for quantifying radioactivity production during a proton treatment of a patient. In some aspects, a method includes administering, using a proton delivery system, a proton treatment using at least one therapeutic proton beam generating positron emitting radionuclides within a region of interest (ROI) of a patient, and acquiring, using an emission tomography system, emission tomography data indicative of an activity of the positron emitting radionuclides in the ROI. The method also includes quantifying, based on a kinetic model, a radioactivity production rate of at least one positron emitting radionuclide using the emission tomography data. The method further includes generating at least one map indicative of the radioactivity production rate of the at least one positron emitting radionuclide.

Abstract: A method is described, including acquiring, using a camera, an image of a radiation beam incident on a phantom, the radiation beam being emitted by a radiation source. The method further includes determining a beam pointing offset based on the image and calibrating a position of the radiation source based on the beam pointing offset. A calibration system is described including the phantom, the camera, and a processing device. A phantom having an X-ray luminescent material is also described.

Abstract: Human and animal infections are treated using extracorporeal acoustic pressure shock waves that destroy harmful pathogens as bacteria, viruses, funguses and other micro-organisms to disinfect infected tissue.

Abstract: This invention relates to skincare compositions, in particular compositions effective in the treatment of acne vulgaris, and to methods of treatment of the skin that involve the application of such compositions, wherein the compositions comprise salicylic acid or a salt thereof in combination with at least two actives selected from the group consisting of lactic acid or a salt thereof; glycyrrhizinic acid or a salt or a derivative thereof; bisabolol; cetylhydroxyproline palmitamide; allantoin; niacinamide; and Epilobium angustifolium extract.

Abstract: There is disclosed a harness for breathing apparatus comprising a structural support member for supporting a vessel of breathable gas, a waist belt, and a pivot joint mechanism coupling the structural support member to the waist belt. The pivot joint mechanism comprises a release part which is movable to decouple the structural support member from the waist belt.

Abstract: An enhanced filtration multilayer laminated fabric includes an air permeable, moisture-vapor-transmissive central layer such as polytetra-fluoroethylene (ePTFE) sandwiched between a first pair of nonwoven textile layers and a second pair of woven textile layers. The laminated fabric may also feature a fire resistant application. The top textile layer may also include a permanent, highly breathable and highly durable electro-static discharge feature added to the inside of the layer by laying down a carbon based printed pattern on the inside of the layer. The filtration fabric may be utilized to manufacture a wearable garment that is aesthetically pleasing and comfortable to wear in all weather conditions and which effectively filters airborne particulates from entering a user's respiratory system by blocking particulates having a size of 0.3 microns and larger from inhaled air for a user's respiratory system with a particle blocking efficiency of at least 90%.